Accurate estimates of future age-specific incidence and mortality are critical for allocation of resources to breast cancer control programs and evaluation of screening programs. The purpose of this study is to apply functional data analysis techniques to model age-specific breast cancer mortality time trends, and forecast entire age-specific mortality function using a state-space approach.
Introduction
Despite an increase in utilization of mammographic screening as a form of early detection, and continual improvements in treatment options, breast cancer remains one of the main causes of mortality and morbidity in women. Regular and accurate estimates of future age-specific incidence and mortality are necessary in making recommendations for the allocation of resources to state, regional and private health care, community-based prevention services and breast cancer control programs.
At present, most forecasting relies on age-period-cohort methods to estimate mortality (and incidence) from breast cancer [1, 2, 3] , prostate cancer [4, 1] and cervical cancer [5, 6] . These models are based on regressions with the outcome defined as mortality or incident cases, and modelled using a Poisson error distribution and a log link function for the mean. The mean is modelled using the sum of parameters for age, period effects (variations in time which may apply to the whole population) and cohort effects (variations due to specific birth cohorts). The fitted models are then used to make linear projections of mortality and incidence. Common problems associated with age-periodcohort models for estimating future cancer rates include issues with non-identifiability of the parameters, strong parametric assumptions, and sensitivity of the projections to most recent changes in cohort effects.
Little other progress has been made in developing statistical methodology for cancer projections, with studies concentrating on variations of age-period-cohort statistical methods. Dyba et al. [7] and Dyba and Hakulinen [8] proposed linear extrapolation and non-linear Poisson distributed models. Each proposal considered a number of different scenarios with known and linearly extrapolated values for period effects and age-specific rates. Bashir and Esteve [3] used a Bayesian age-period-cohort model with autoregressive smoothing of each of the age, period and cohort components so that the resulting projections are estimated from current and past smoothed trends of the data.
We present an alternative approach to forecasting cancer mortality and incidence. This method was recently developed for demographic forecasting [9] and has not previously been applied to cancer projections. The approach uses functional data analysis techniques, and treats the age-specific mortality curves as the units of analysis rather than the discrete observations. In recent years, functional data analysis has received much attention, particularly in medicine. Ramsay and Silverman [10] provide a comprehensive introduction and have stimulated much additional development of these methods.
The Hyndman-Ullah [9] approach is a generalization of the method of Lee and Carter [11] , and has the following advantages: a) mortality (or incidence) rates are modelled as continuous functions of age so that subtle patterns of variation between years are captured; b) data are smoothed prior to estimating the basis functions, thus reducing observational error; c) the approach forecasts the entire function for future time periods with prediction intervals; d) the method is robust to outlying years; and e) the flexibility of the approach allows the incorporation of important covariates such as screening and treatment effects into the modelling. The purpose of this study is to demonstrate the utility of this new modelling and forecasting method for estimating future age-specific trends in breast cancer mortality, using unadjusted age-specific data for Australia from 1921 to 2001.
Methods Data
In this study we obtained data on mortality from breast cancer in Australian women from the Australian Institute of Health and Welfare (AIHW), an organization that provides deidentified health and welfare data to national and regional government and community organizations. National mortality data are compiled from medical certificates outlining cause of death from the Registrar of Births, Deaths and Marriages located in each state and territory. Additional diagnostic information is also available from the state-and territory-based cancer registries. 
Functional data analysis
With functional data methods, data can be smooth curves or functions. In the case of age-specific mortality, mortality rates are treated as smooth functions of age.
Let y t (x) denote the log mortality rate for age x and year t, t = 1, . . . , n. We assume there is an underlying smooth function f t (x) that we are observing with error. Thus,
where x i is the centre of age-group i (i = 1, . . . , p), ε t,i is an independent and identically distributed standard normal random variable and σ t (x i ) allows the amount of noise to vary with age x.
Various smoothing techniques are available to estimate the function from the discrete observations. We smooth the data using local quadratic smoothing with the smoothing parameter (the "bandwidth") selected using cross-validation [13]
The smooth curves are our functional observations, {f t (x)}, x 1 < x < x p , t = 1, . . . , n.
After constructing the functional observations, we fit the model
where µ(x) is the mean log mortality rate across years, φ k (x) is a set of orthogonal basis functions, and e t (x) is the model error.
We wish to estimate the optimal set of K orthogonal basis functions. Specifically, for a given K, we want to find the basis functions {φ k (x)} which minimize the mean integrated squared error:
This is achieved using functional principal components decomposition [14] which gives the least number of basis functions, enables more informative interpretations and gives coefficients which are uncorrelated with each other.
Hyndman and Ullah [9] proposed a robust method to estimate µ(x) and a robust approach to obtaining principal components when computing the basis functions. However, our data do not exhibit any outliers or other unusual behaviour, and so we use the mean and standard (functional) principal component decomposition.
To assess the overall goodness of fit, the residuals of the fitted mortality model are displayed using image plots.
Forecasting framework
We estimate future values of mortality y t (x i ) by forecasting the entire function f t (x) for t = n + 1, . . . , n + h and x 1 < x < x p . The coefficients of the fitted function, β t,1 , . . . , β t,K , are forecast using time series models. The forecast coefficients are then multiplied by the basis functions, resulting in forecasts of mortality curves. Hyndman and Ullah [9] show how to obtain prediction intervals for the forecast curves.
Letβ n,k,h denote the h-step ahead forecast of β n+h,k and letf n,h (x) denote the h-step
To forecast the coefficients in equation (4) We evaluate the accuracy of the mortality forecasts by computing the Mean Integrated Squared Forecasting Error (MISFE) defined as
where m is the minimum number of observations used in fitting a model. In our implementation, we set m = 10.
All analyses were performed using the R implementation of the S language [18] . had relatively stable mortality rates from 1960 to the late 1990s, and all show a decline in mortality over the last few years. The greatest rate of decline has been in women 65 years and over. In general, mortality increases with age, and in each year, maximum mortality occurred in women over 85 years.
Results
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Crude log mortality rates by age for 1941, 1961, 1981 and 2001 are displayed in Figure 2 .
We smooth the log mortality series by age using loess (locally quadratic) regression with the bandwidth chosen via cross-validation. The fitted smooth curves are overlaid on the observed discrete log mortality rates. Similar trends in the age-mortality relation were observed in each year. Although mortality rates increase with age, the rate of increase varies across age groups. In most years, there is a slight deceleration in the rate of increase for women 60 to 70 years of age, and a rapid acceleration thereafter.
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We computed 20 year estimates of future age-specific breast cancer mortality using statespace exponential smoothing models as described by Hyndman et al. (2002) . The automatic model-selection algorithm chose models with additive errors and a damped trend.
The model parameters were selected by minimization of the one-step MSE.
Forecasts of β t,1 are shown in Figure 4 for 2002 to 2021, along with 80% prediction intervals. This parameter controls the overall change in trend in breast cancer mortality. In Australian women, mortality from breast cancer is expected to continue to decline at a slower rate than that suggested by observed mortality trends during the late 1990s, and expected to level off and stabilize beyond 2010. Note that the wide prediction intervals provide a measure of the uncertainty in the future movements in this coefficient, and even allow for it to increase.
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One-year and ten-year Age-specific breast cancer log mortality forecasts are shown in Figure 5 , along with 80% prediction intervals. Very little difference in the overall shape of the age-mortality trends is likely to occur over the forecast horizon. In all age groups, the forecasts show a decline in breast cancer mortality, with the greatest declines in the oldest age groups.
Discussion
At present, statistical methods for mortality projections assume current age-adjusted breast cancer mortality trends will continue into the future, thereby projecting a continual rate of decline in breast cancer mortality in countries such as the United States, the United Kingdom, Canada, New Zealand and Australia.
In this study of breast cancer mortality in Australian women, we illustrate the utility of a new forecasting method that models mortality using a functional model of age. The model uses basis expansions which highlight important trends in the mortality-age relationship for the period of the study. Future mortality rates are then estimated using all available historical data rather than only the most recent observations. Using our approach, the forecast horizon suggests a slower rate of decline in breast cancer mortality in Australian women within the next decade, stabilizing beyond 2010. Our data suggest relatively small changes in mortality for women 50 to 60 years of age who are at the lower end of the target age group for screening, assuming current screening and treatments are unchanged.
In Australia, crude mortality rates have increased during 1920-1940, decreased post war, remained relatively stable during 1960-1980, followed by a steady decline since the mid1990s. However, when crude mortality rates are age-standardized to the world population, Australian mortality trends follow a similar pattern to other Western countries such as the United States, the United Kingdom, Canada and New Zealand [19, 20] . In these countries, mortality rates have shown very little variation beyond 1950 except for the more recent steady decline which began in the 1990s.
The reduction in mortality over the last decade is most likely a result of improvements in treatment regimes such as increased utilization of adjuvant therapy and increased mammographic screening. In the United States substantial improvements in survival among postmenopausal women were observed following new treatment regimes in addition to tamoxifen [21] . The United Kingdom has adopted tamoxifen treatments in nearly all women over 50 years of age in the early 1990s [22] . Australia has seen similar improvements in adjuvant chemotherapy and hormonal therapy treatment regimes [23] and in 1995 new management guidelines for breast cancer treatment were widely adopted [24] .
The more recent reduction in breast cancer mortality rates may in part be explained by the delayed mortality benefit of mammographic screening.
Although the interpretation of randomized control trials of mammographic screening is still subject to some controversy [25] , the evidence suggests an approximately 30% reduction in mortality in screened populations due to early detection of tumours. In many countries, participation in mammographic screening has gradually increased since its introduction in the late 1980s and early 1990s. In Australia, 57% of women in the target age group for screening (50 to 69 years) were screened within a national BreastScreen program in 2001-2002 [12] . Participation rates are much higher in the United States with 78.6% of women between 50-64 years of age reported as having a mammogram in the previous two years [26] .
Blanks et al. [2] predicted mortality from breast cancer for England and Wales using the widely used age-period-cohort approach. They provide mortality predictions separately for different age groups in the presence and absence of screening for the period 1990-1999. Although they do not extrapolate beyond 1999, their findings suggest a constant decline in overall mortality, with a slight decline and then levelling off in women 50 to 65 years of age and an increase in women over 70 years of age. In this study we adopt a methodological approach which models age as a functional covariate rather than a fixed variable, so that the age-shape of mortality varies over time, thereby enabling the models and forecasts to pick up subtle variations. Other studies in demography have also realized the implications of this phenomenon when modeling all-cause mortality, particularly the acceleration in the rate of mortality decline in older persons [28, 29] .
Functional data analysis is an effective exploratory and modelling technique for highlighting trends and variations in the shape of the age-mortality relationship over time.
This analytical approach has a number of strengths. First, in contrast to the common ageperiod-cohort models used to model trends in mortality, functional data analysis techniques make no parametric assumptions about age or period effects. The shape of the mortality-age curve varies with time, so that at different ages, mortality declines at different rates. This phenomenon is particularly apparent in breast cancer mortality, possibly due to hormonal effects or screening of women in target age groups. To our knowledge, no other study has modelled or forecast from a model with age as a functional covariate of breast cancer mortality over time.
Second, using a functional approach to forecast age-specific mortality models the entire age function and allows the possibility of a damped trend component, thereby provid-ing greater accuracy when forecasting age-specific mortality for future time periods. The damped trend is particularly useful for forecasting breast cancer mortality because in recent years mortality from breast cancer has continued to decrease. Rather than assuming a continual decline into the future, the damping factor decelerates the trend component for the forecast horizon. In other forecasting applications [30] , a damped trend model has proved particularly accurate for forecasting.
Functional data analysis methods can be further developed to incorporate interventions such as screening effects and covariates for hormone replacement therapy use. In addition, the shape of the age-mortality relation can be allowed to vary for different types of cancers and would be particularly useful for forecasting incidence of breast cancer.
A potential limitation of this approach is the assumption that there are only period effects and no cohort effects. Examination of the residuals from the functional fit revealed very little birth cohort effects in breast cancer mortality in Australia. Furthermore, studies of breast cancer mortality in different countries using age-cohort mortality models also support our finding of constant cohort mortality ratios from breast cancer in Australian women [19] . However, birth cohort effects are an important component of modelling mortality trends and studies have shown strong birth cohort effects in mortality trends for the United Kingdom, Canada, the United States and Scotland [19, 31, 32] .
Often birth cohort effects influence mortality trends in younger and older age groups [33] . Our modelling approach smooths the data prior to fitting the functional regression model, resulting in a smoothed functional age-mortality relation. The smoothing process may reduce much of the variation attributable to outlying observations at younger and older age groups where we expect birth-cohort trends to have the greatest effect. Any remaining birth-cohort trend is saturated in patterns of variation over time. This is not necessarily a problem as it does not hinder the functional age-mortality association over time, which is the focus of these studies. In future work, we intend to extend our model to allow for cohort effects.
In summary, we have demonstrated the utility and flexibility of this newly developed approach to forecast age-specific mortality from breast cancer. Our estimates suggest mortality from breast cancer will continue to decline and then stabilize beyond 2010 with the greatest decline in oldest age groups. These models also have broader application to other cancers and chronic diseases. 
